Omecamtiv mecarbil brings greater benefits for severe heart failure
The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the ...
May 17, 2021
0
6